Evidence map›Paper›PMID 34412837›Full record

ArticleArtificial intelligence in medicine2021

An explainable AI system for automated COVID-19 assessment and lesion categorization from CT-scans.

Matteo Pennisi, Isaak Kavasidis, Concetto Spampinato, Vincenzo Schinina, Simone Palazzo, Federica Proietto Salanitri, Giovanni Bellitto, Francesco Rundo, Marco Aldinucci, Massimo Cristofaro and 8 more

Abstract read
In one paragraph

Article in Artificial intelligence in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Artificial Intelligence and Infectious Disease Imaging.The Journal of infectious diseases · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Explaining COVID-19 diagnosis with Taylor decompositions.Neural computing & applications · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Matteo PennisiDIEEI, University of Catania, Catania, Italy.
Isaak KavasidisDIEEI, University of Catania, Catania, Italy. Electronic address: kavasidis@dieei.unict.it.
Concetto SpampinatoDIEEI, University of Catania, Catania, Italy.
Vincenzo SchininaNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Simone PalazzoDIEEI, University of Catania, Catania, Italy.
Federica Proietto SalanitriDIEEI, University of Catania, Catania, Italy.
Giovanni BellittoDIEEI, University of Catania, Catania, Italy.
Francesco RundoSTMicroelectronics - ADG Central R&D, Catania, Italy.
Marco AldinucciDepartment of Computer Science, University of Turin, Turin, Italy.
Massimo CristofaroNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Paolo CampioniNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Elisa PianuraNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Federica Di StefanoNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Ada PetroneNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Fabrizio AlbarelloNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Giuseppe IppolitoNational Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.
Salvatore CuzzocreaChimBioFaram Department, University of Messina, Messina, Italy.
Sabrina ConociChimBioFaram Department, University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 infection caused by SARS-CoV-2 pathogen has been a catastrophic pandemic outbreak all over the world, with exponential increasing of confirmed cases and, unfortunately, deaths. In this work we propose an AI-powered pipeline, based on the deep-learning paradigm, for automated COVID-19 detection and lesion categorization from CT scans. We first propose a new segmentation module aimed at automatically identifying lung parenchyma and lobes. Next, we combine the segmentation network with classification networks for COVID-19 identification and lesion categorization. We compare the model's classification results with those obtained by three expert radiologists on a dataset of 166 CT scans. Results showed a sensitivity of 90.3% and a specificity of 93.5% for COVID-19 detection, at least on par with those yielded by the expert radiologists, and an average lesion categorization accuracy of about 84%. Moreover, a significant role is played by prior lung and lobe segmentation, that allowed us to enhance classification performance by over 6 percent points. The interpretation of the trained AI models reveals that the most significant areas for supporting the decision on COVID-19 identification are consistent with the lesions clinically associated to the virus, i.e., crazy paving, consolidation and ground glass. This means that the artificial models are able to discriminate a positive patient from a negative one (both controls and patients with interstitial pneumonia tested negative to COVID) by evaluating the presence of those lesions into CT scans. Finally, the AI models are integrated into a user-friendly GUI to support AI explainability for radiologists, which is publicly available at http://perceivelab.com/covid-ai. The whole AI system is unique since, to the best of our knowledge, it is the first AI-based software, publicly available, that attempts to explain to radiologists what information is used by AI methods for making decisions and that proactively involves them in the decision loop to further improve the COVID-19 understanding.

Indexed as

COVID-19Artificial IntelligenceHumansLungSARS-CoV-2Tomography, X-Ray ComputedCOVID-19 detectionDeep learningLung segmentation

Identifiers

PMID34412837
PMCPMC8139171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.